Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: distinction of two groups of patients according to predictable prognosis.
D000293:Adolescent; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002452:Cell Count; D002648:Child; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D008297:Male; D011379:Prognosis; D012075:Remission, Spontaneous; D013997:Time Factors
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D001500:BCG Vaccine